Shibuya-ku, Tokyo, Japan, Japan, May 13, 2022, 08:02 /Comserve / -- The report predicts the global North America Injectable Drug Delivery Market to grow with a CAGR of 12.3% over the forecast period from 2022-2031.
The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2031 at a CAGR of 12.3% from 2022 To 2031. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The North American injectable drug delivery formulations technologies market was the largest segment in this market. In addition, the market is segmented on the basis of its therapeutic applications. In the therapeutic area, hormonal disorders command the major segment of the injectable drug delivery technologies market due to the high demand for injectables in the treatment of diabetes. However, auto-immune diseases are the fastest-growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self-injection devices.
The major markets covered in this report are the United States and Canada. The United States accounted for the largest market of the North American injectable drug delivery technologies market in the year 2012. However, Canada is expected to witness high growth due to the growing prevalence of diabetes and autoimmune diseases such as multiple sclerosis and rheumatoid arthritis, an increase in approval of injectable formulations and devices, favorable reimbursement, and a rise in injectable cosmetic treatments.
The growth of the injectable drug delivery technologies market is driven by factors such as innovations in injectable drug delivery devices, rising prevalence of diabetes in the U.S. and Canada, improving patient compliance, and a rise in partnerships, collaborations, and acquisitions among prominent players in this market. However, factors such as product recall, regulatory hurdles for approval of new device sand formulations, and needle-stick injuries and infections, are restraining the growth of the market.
Download The Sample PDF Report Here: https://www.sdki.jp/sample-request-59225
Scope of the Report
This research report categorizes and analyzes the North American injectable drug delivery technologies market under two broad segments - devices and formulations. Both of these markets are broken down into segments and sub-segments, providing exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2031. Furthermore, due to the wide range of applications of injectable drug delivery technologies in varied therapeutic areas, the market is segmented into five categories, namely; autoimmune diseases, hormonal imbalances, oncology, orphan/rare diseases (Hemophilia, Ribose-5-phosphate isomerase deficiency (RPI deficiency), Cystic Fibrosis, Wilson’s Disease) and others (pain management, allergies, hepatitis C, and aesthetic treatment). Each market is comprehensively analyzed at a granular level by country (United States and Canada) to provide in-depth information on the North American scenario.
Injectable Drug Delivery Technologies Market, By Segment
Injectable Drug Delivery Devices Technologies
Injectable Drug Delivery Formulations Technologies
Injectable Drug Delivery Devices Technologies Market, By Product
Conventional Injection Devices
By Materials
Glass
Plastics
By Product
Fillable Syringes
Prefilled Syringes
By Usability
Reusable
Disposable
Self-Injection Devices
Needle-Free Injectors
By Product
Fillable Syringes
Prefilled Syringes
By Technology
Jet-based Needle-Free Injectors
Spring-based Needle-Free Injectors
Laser-Powered Needle-Free Injectors
Others
By Usability
Reusable
Disposable
Auto-Injectors
By Product
Fillable Syringes
Prefilled Syringes
By Technology
Manual Injection Auto-Injectors
Automated Injection Auto-Injectors
By Design
Standardized Auto-Injectors
Customized Auto-Injectors
By Usability
Reusable
Disposable
Pen Injectors
By Product
Single Chambered Pen Injectors
Dual Chambered Pen Injectors
By design
Standardized pen injectors
Customized pen injectors
By usability
Reusable
Disposable
Others (blunt needle, microneedle, and nanoneedle injections)
Request The Sample PDF Report Here: https://www.sdki.jp/sample-request-59225
Injectable Drug Delivery Formulations Technologies, By Product
Conventional Drug Delivery Formulation
Solution
Reconstituted / Lyophilized Formulation
Novel Drug Delivery Formulation
Liposomal Systems
Microspheres
Nanoparticles
Polymeric Micelles
Others (dendrimers, nanosponge, and nanoemulsions)
Injectable Drug Delivery Technologies Market, B y Therapeutic Applications
Auto-Immune Diseases
Multiple Sclerosis
Rheumatoid Arthritis
Crohn's Diseases
Psoriasis
Others
Hormonal Disorders
Diabetes
Antithrombotic/Thrombolytic Therapy
Reproductive Health Diseases
Anemia
Osteoporosis
Others
Orphan Diseases
Oncology
Others
Pain Management
Allergies
Hepatitis C
Aesthetic Treatment
Click Here To Get The Sample PDF Report: https://www.sdki.jp/sample-request-59225
The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.
For more information, please contact:
Lauren BrownShibuya Data Count
Email: sales@sdki.jp
Tel: + 81 50 50509159
Related Links
https://www.sdki.us/